Boston, MA -- (SBWIRE) -- 09/11/2013 -- Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner.Chartpoppers.com issues news alert on the following stocks:- 22nd Century Group Inc(OTCBB:XXII), OSISKO MINING CORP(OTCMKTS:OSKFF), Titan Pharmaceuticals, Inc.(OTCBB:TTNP), Novadel Pharma Inc(OTCMKTS:NVDL)
22nd Century Group Inc(OTCBB:XXII), during the previous trading period, showed a positive activity of +0.90%. Currently, the company has a market capital of $53.85 billion dollars. The stock’s final trade was made at $1.12, while it had started its day-trade at $1.10. In the past 52-week period, the stock has not gone below $0.15 and traded at maximum level of $1.74. 22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.
For How Long XXII will Fight for Profitability? Read This Trend Analysis report
OSISKO MINING CORP(OTCMKTS:OSKFF) completed latest trade -4.59% lower at $4.7933from prior close of $4.7933. It was exchanged between $4.73– 4.97with 85.34k in overall exchanged numbers of shares. Osisko Mining Corporation engages in acquiring, exploring, developing, and mining gold properties in the Americas. The company principally owns and operates the Canadian Malartic gold mine located near Malartic in Québec; Hammond Reef gold project located near Thunder Bay in Northern Ontario; and Upper Beaver-Kirkland Lake gold properties located in Northeastern Ontario. The company was formerly known as Osisko Exploration Ltée and changed its name to Osisko Mining Corporation in May 2008. Osisko Mining Corporation was incorporated in 1982 and is headquartered in Montreal, Canada.
Has OSKFF Found The Bottom And Ready To Gain Momentum? Find Out Here
Titan Pharmaceuticals, Inc.(OTCBB:TTNP) decreased -0.80% to close at $0.62 in the last trading session and its total traded volume was 469.84k shares versus average volume of 181,814.00. The company has market cap of $51.18 billion.
The stock has negative year-to-date performance of 12.20% while its quarterly performance remained 10.44%. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.
Why Should Investors Buy TTNP After the Recent Fall? Just Go Here and Find Out
Novadel Pharma Inc(OTCMKTS:NVDL) declined -21.33% to end at $0.0059 and its overall volume in the last trading session was 469.84k shares, versus average trading volume of 623,813.00. It has market cap of $16.62 billion while its total outstanding shares are 134.89 million.
The stock declined -96.72% in this year and reported the loss -96.72% in the last 5 days. The stock 3 month performance stands at -96.72%. NovaDel Pharma Inc., a specialty pharmaceutical company, develops oral spray formulations for marketed pharmaceuticals.
Will NVDL Get Buyers Even After The Recent Rally? Find Out Here
Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit chartpoppers right now and see what it’s all about for yourself! At 50,000 Visitors a Month and growing rapidly chartpoppers is the hottest thing in Penny Stocks!
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ChartPoppers.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ChartPoppers.com is owned and operated by One22 Media,LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ChartPoppers’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ChartPoppers or an offer or solicitation to buy or sell any security. Neither the owner of ChartPoppers nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters.
Read Full Disclaimer at: http://chartpoppers.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)